Targeting CD38 with Daratumumab for Platelet Transfusion Refractoriness in Aplastic Anemia. Gao Z, Pan H, Zhang L, Li W, et al. Blood 2025 May 7:blood.2025029006. doi: 10.1182/blood.2025029006.

Read + Share

Amedeo Smart

Independent Medical Education

Gao Z, Pan H, Zhang L, Li W, et al. Targeting CD38 with Daratumumab for Platelet Transfusion Refractoriness in Aplastic Anemia. Blood 2025 May 7:blood.2025029006. doi: 10.1182/blood.2025029006.
PMID: 40331918